• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetic parameters of 14C oxithiopurinol in rat.

作者信息

Pasquier C, Auscher C

出版信息

Eur J Drug Metab Pharmacokinet. 1979;4(2):59-65. doi: 10.1007/BF03189402.

DOI:10.1007/BF03189402
PMID:488133
Abstract

The study with labelled compound has shown that in rat, as in man, thiopurinol is primarily and rapidly converted into oxithiopurinol. More than 80% of the radioactivity of plasma was identified as oxithiopurinol less than 10 minutes after intravenous or oral administration. The parameters of oxithiopurinol were estimated from the decline of radioactivity in blood from 5 minutes to 8 hours after intravenous administration of 4 microCi/100 g of thiopurinol (8 animals) or oxithiopurinol (5 animals). Half lives of oxithiopurinol t 1/2 (beta) were 2.52 +/- 0.78 hr and 2.90 +/- 1.00 hr and clearance 2.00 +/- 0.36 ml/min. and 3.38 +/- 0.69 respectively. Estimate of renal clearance for oxithiopurinol in rat was 4,17 ml/min. The rapidity of hydroxylation and of elimination of oxithiopurinol might be assumed to be the cause of the apparent ineffectiveness of thiopurinol in vivo on xanthine oxidase activity.

摘要

相似文献

1
Pharmacokinetic parameters of 14C oxithiopurinol in rat.
Eur J Drug Metab Pharmacokinet. 1979;4(2):59-65. doi: 10.1007/BF03189402.
2
[Methods of isolation and determination of urinary 4-thio-6-hydroxypyrazolo(3,4 d)pyrimidine in patients treated with thiopurinol].[硫嘌呤醇治疗患者尿中4-硫代-6-羟基吡唑并(3,4-d)嘧啶的分离与测定方法]
Ann Biol Clin (Paris). 1975;33(1):15-9.
3
The effect of dietary protein on the clearance of allopurinol and oxypurinol.膳食蛋白质对别嘌醇和氧嘌呤醇清除率的影响。
N Engl J Med. 1985 Sep 26;313(13):771-6. doi: 10.1056/NEJM198509263131302.
4
Sustained reductions in oxipurinol renal clearance during a restricted diet.
Clin Pharmacol Ther. 1987 Jun;41(6):616-21. doi: 10.1038/clpt.1987.84.
5
Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.反式甲基苯乙烯基酮在雄性费希尔344大鼠体内的口服和局部吸收、处置动力学及代谢命运
Drug Metab Dispos. 1997 Jun;25(6):732-9.
6
Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.别嘌醇和氧嘌呤醇的临床药代动力学与药效学
Clin Pharmacokinet. 2007;46(8):623-44. doi: 10.2165/00003088-200746080-00001.
7
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
8
Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.2,4-戊二酮在Fischer 344大鼠体内的急性静脉注射和吸入药代动力学
Toxicol Ind Health. 1998 May-Jun;14(3):413-28. doi: 10.1177/074823379801400303.
9
Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.新型降胆固醇化合物S-8921在大鼠和犬体内的处置与代谢
Arzneimittelforschung. 1998 Oct;48(10):995-1006.
10
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.硫酸氨基葡萄糖的吸收、分布、代谢及排泄。综述
Arzneimittelforschung. 2001 Sep;51(9):699-725. doi: 10.1055/s-0031-1300105.

本文引用的文献

1
Clearance of allantoin in the rat and dog as a measure of glomerular filtration rates.以大鼠和犬中尿囊素的清除率作为肾小球滤过率的一种衡量指标。
Am J Physiol. 1947 Nov 1;151(1):192-7. doi: 10.1152/ajplegacy.1947.151.1.192.
2
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.黄嘌呤氧化酶抑制剂别嘌醇的代谢研究。
Biochem Pharmacol. 1966 Jul;15(7):863-80. doi: 10.1016/0006-2952(66)90163-8.
3
[Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].用巯基吡唑并嘧啶(硫嘌呤醇)治疗痛风性嘌呤代谢紊乱
Presse Med (1893). 1968 Dec 14;76(49):2329.
4
Renal clearance of oxipurinol, the chief metabolite of allopurinol.
Am J Med. 1968 Jul;45(1):69-77. doi: 10.1016/0002-9343(68)90008-9.
5
Urinary excretion of 6 hydroxylated metabolite and oxypurines in a xanthinuric man given allopurinol or thiopurinol.给黄嘌呤尿症患者服用别嘌呤醇或硫嘌呤醇后其6-羟基化代谢物和氧嘌呤的尿排泄情况。
Adv Exp Med Biol. 1974;41:663-7. doi: 10.1007/978-1-4757-1433-3_37.
6
Mechanism of antiuric action of 4-oxy- and 4-thiopyrazolopyrimidines.4-氧代和4-硫代吡唑并嘧啶的抗尿酸作用机制
Biochem Pharmacol. 1973 Dec 1;22(23):3061-75. doi: 10.1016/0006-2952(73)90193-7.
7
[Molecular bases of the treatment of Lesch-Nyhan syndrome, related syndromes and common gout].[莱施-奈恩综合征、相关综合征及普通痛风的治疗分子基础]
Biochimie. 1972;54(5):709-21.
8
Thiopurinol and purine metabolism. Metabolic and radioisotope studies.硫唑嘌呤与嘌呤代谢。代谢及放射性同位素研究。
Ann Rheum Dis. 1974 Nov;33(6):548-53. doi: 10.1136/ard.33.6.548.
9
[Uric acid inhibitors in the treatment of gout. Apropos of 126 cases].
Sem Hop. 1970 Dec 8;46(50):3295-301.
10
[Methods of isolation and determination of urinary 4-thio-6-hydroxypyrazolo(3,4 d)pyrimidine in patients treated with thiopurinol].[硫嘌呤醇治疗患者尿中4-硫代-6-羟基吡唑并(3,4-d)嘧啶的分离与测定方法]
Ann Biol Clin (Paris). 1975;33(1):15-9.